» Articles » PMID: 21173170

Early Natural History of Incident, Type-specific Human Papillomavirus Infections in Newly Sexually Active Young Women

Overview
Date 2010 Dec 22
PMID 21173170
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Characterizing short-term detection patterns of young women's incident α-genus human papillomavirus (HPV) infections may further our understanding of HPV transmission.

Methods: Between 2000 and 2007, we followed 18- to 22-year-old female university students with triannual HPV DNA and Papanicolaou testing. Using Kaplan-Meier methods, we estimated duration of detectable, type-specific incident infections; time to redetection (among infections that became undetectable); and time to cervical lesion development after incident infection. We evaluated risk factors for short-term persistent versus transient infection with logistic regression.

Results: Three hundred three incident, type-specific infections were detected in 85 sexually active women. Median time to first negative test after incident infection was 9.4 (95% CI: 7.8-11.2) months; 90.6% of infections became undetectable within 2 years. About 19.4% of infections that became undetectable were redetected within 1 year. Cervical lesions were common and 60% were positive for multiple HPV types in concurrent cervical swabs. Incident HPV detection in the cervix only (vs. the vulva/vagina only or both sites) was associated with short-term transience.

Conclusions: Although most incident infections became undetectable within 2 years, redetection was common. Cervical lesions were a common early manifestation of HPV infection.

Impact: It remains unclear whether potentially modifiable risk factors can be identified to reduce infection duration (and transmission likelihood).

Citing Articles

Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer.

Kan X, Zhou Z, Liu L, Aiskikaer R, Zou Y Heliyon. 2025; 11(3):e42055.

PMID: 39916829 PMC: 11800076. DOI: 10.1016/j.heliyon.2025.e42055.


Association of female genital schistosomiasis and human papillomavirus and cervical pre-cancer: a systematic review.

Sturt A, Omar T, Hansingo I, Kamfwa P, Bustinduy A, Kelly H BMC Womens Health. 2025; 25(1):2.

PMID: 39754189 PMC: 11697648. DOI: 10.1186/s12905-024-03514-0.


Prevalence and Genotyping of Human Papillomavirus Infections in Females and Males in Zhejiang, China.

Wang Y, Weng J, Wu Q, Wen J, Gao Q, Lu W Infect Drug Resist. 2024; 17:5325-5334.

PMID: 39628831 PMC: 11613703. DOI: 10.2147/IDR.S484519.


Community intervention of a single-dose or 2-dose regimen of bivalent human papillomavirus vaccine in schoolgirls in Thailand: vaccine effectiveness 2 years and 4 years after vaccination.

Jiamsiri S, Rhee C, Ahn H, Seo H, Klinsupa W, Park S J Natl Cancer Inst Monogr. 2024; 2024(67):346-357.

PMID: 39529526 PMC: 11555278. DOI: 10.1093/jncimonographs/lgae036.


High-risk HPV Prevalence Estimates among Older Patients: Implications for Cervical Cancer Screening Programs.

Mittal S, Kansal Y, Singh B, Gupta V Indian J Community Med. 2024; 49(4):599-603.

PMID: 39291120 PMC: 11404415. DOI: 10.4103/ijcm.ijcm_800_22.


References
1.
Castle P, Rodriguez A, Porras C, Herrero R, Schiffman M, Gonzalez P . A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis. 2007; 34(11):849-55. PMC: 3962831. DOI: 10.1097/OLQ.0b013e318064c8c5. View

2.
Winer R, Harris T, Xi L, Jansen K, Hughes J, Feng Q . Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development. J Med Virol. 2009; 81(4):713-21. PMC: 3984467. DOI: 10.1002/jmv.21450. View

3.
Winer R, Hughes J, Feng Q, OReilly S, Kiviat N, Holmes K . Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med. 2006; 354(25):2645-54. DOI: 10.1056/NEJMoa053284. View

4.
Castle P, Jeronimo J, Schiffman M, Herrero R, Rodriguez A, Bratti M . Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 2006; 66(2):1218-24. DOI: 10.1158/0008-5472.CAN-05-3066. View

5.
Bosch F, Burchell A, Schiffman M, Giuliano A, de Sanjose S, Bruni L . Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008; 26 Suppl 10:K1-16. DOI: 10.1016/j.vaccine.2008.05.064. View